Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma Meeting Abstract


Authors: Kitano, S.; Postow, M. A.; Cortez, C.; Rasalan, T.; Gallardo, H. F.; Panageas, K.; Yuan, J.; Wolchok, J. D.; Lesokhin, A. M.
Abstract Title: Myeloid-derived suppressor cell quantity prior to treatment with ipilimumab at 10mg/kg to predict for overall survival in patients with metastatic melanoma
Meeting Title: 48th Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 30
Issue: 15 Suppl.
Meeting Dates: 2012 Jun 1-5
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2012-05-20
Language: English
ACCESSION: WOS:000318009801609
PROVIDER: wos
DOI: 10.1200/jco.2012.30.15_suppl.2518
Notes: Meeting Abstract: 2518 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Jedd D Wolchok
    905 Wolchok
  2. Michael Andrew Postow
    361 Postow
  3. Katherine S Panageas
    512 Panageas
  4. Jianda Yuan
    105 Yuan
  5. Shigehisa Kitano
    12 Kitano
  6. Alexander Meyer Lesokhin
    363 Lesokhin
  7. Teresa Rasalan
    33 Rasalan
  8. Czrina Anne Cortez
    8 Cortez